Dexmedetomidine as Adjunct to Local Anesthetic Improves Pain, Function & Satisfaction After TKA .
Dexmedetomidine as an adjunct to local anesthetics in nerve block relieved pain more effectively after TKA: a meta-analysis of randomized controlled trials.
J Orthop Surg Res. 2020 Dec 1;15(1):577.Seven studies including a total of 546 patients undergoing primary total knee arthroplasty (TKA) were included in this meta-analysis comparing dexmedetomidine as an adjunct to local anesthesia in nerve blockade or local anesthesia alone. The primary outcomes of interest included the pooled pain scores at rest and during motion. Secondary outcomes of interests included pooled opioid consumption, analgesia duration, patient satisfaction, motor strength, degree of sedation, risk of post-operative nausea and vomiting, and total complications. Studies assessed outcomes within the first 2 days post-operation. Pooled pain scores, both at rest and during motion, were statistically significantly in favour of the dexmedetomidine group at 6, 12, 24, and 48 hours post-operation (p<0.05 for all). Pooled opioid consumption 24 hours post-operation (p<0.001), analgesia duration (p<0.001), patient satisfaction (p<0.001), motor strength (p=0.04), and sedation degree at 24 hours (p<0.001) and 48 hours (p<0.001) post-operation were statistically significantly in favour of the dexmedetomidine group. No statistically significant differences in the pooled risk of nausea and vomiting (p=0.14) or total complications (p=0.89) were observed between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics